COMMUNIQUÉS West-GlobeNewswire

Cesca Therapeutics Inc. Announces Commercial Launch of AXP® II System for Advanced Cord Blood Processing
26/02/2018
RANCHO CORDOVA, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]
Protalix BioTherapeutics to Hold Full-Year 2017 Financial Results and Corporate Update Conference Call on March 6, 2018
26/02/2018
CARMIEL, Israel, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE: PLX ), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
Axsome Therapeutics Announces Primary Endpoint Met in Phase 1 Trial of Next Generation Product Candidate AXS-09 Containing Chirally Pure Esbupropion and Dextromethorphan
26/02/2018
Chirally pure and stable single enantiomers of bupropion achieved AXS-09 consists of esbupropion and dextromethorphan for CNS disorders Esbupropion is the chirally pure S -enantiomer of bupropion AXS-09 results in [...]
Edge Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results Conference Call on March 1, 2018
26/02/2018
BERKELEY HEIGHTS, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE ), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life- [...]
Resverlogix Announces Sixth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone
26/02/2018
CALGARY, Alberta, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX ) today announced that the independent Data and Safety Monitoring Board (DSMB) for the Company's Phase 3 [...]
Achillion Announces ACH-4471 Receives Positive Opinion for Orphan Drug Designation in the European Union for the Treatment of C3 Glomerulopathy
26/02/2018
NEW HAVEN, Conn., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ), a biopharmaceutical company focused on advancing small molecule factor D inhibitors to modulate the complement [...]
Orion Group Financial Statement documents 2017 and Corporate Governance Statement published
26/02/2018
ORION CORPORATION STOCK EXCHANGE RELEASE 26 FEBRUARY 2018 at 13.00 EET Orion Group Financial Statement documents 2017 and Corporate Governance Statement published Orion Group's Financial Statement documents for 2017 [...]
Orion Group Financial Statement documents 2017 and Corporate Governance Statement published
26/02/2018
ORION CORPORATION STOCK EXCHANGE RELEASE 26 FEBRUARY 2018 at 13.00 EET Orion Group Financial Statement documents 2017 and Corporate Governance Statement published Orion Group's Financial Statement documents for 2017 [...]
Ascension Selects R1 for Physician Practice Revenue Cycle Management
26/02/2018
CHICAGO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced plans for an expanded 10-year [...]
OraSure Technologies to Present at the Raymond James 39th Annual Institutional Investors Conference
26/02/2018
BETHLEHEM, Pa., Feb. 26, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, [...]
R1 to Acquire Intermedix Corporation
26/02/2018
CHICAGO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc . (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced a definitive agreement to [...]
Bavarian Nordic Announces Collaboration to Evaluate CV301 in Combination with durvalumab in Colorectal and Pancreatic Cancers
26/02/2018
Third evaluation of CV301 in combination with a checkpoint inhibitor Multicenter investigator-sponsored trial to be led by Georgetown University COPENHAGEN, Denmark, February 26, 2018 - Bavarian Nordic A/S (OMX: BAVA, [...]
William Demant Holding A/S: Notice to annual general meeting
26/02/2018
To the shareholders of William Demant Holding A/S 26 February 2018 Notice is hereby given of the Annual General Meeting of William Demant Holding A/S to be held on: Thursday, 22 March 2018 at 4:00pm CET at the Company's [...]
Acarix : Year-end Report, January - December 2017
26/02/2018
Press release Malmö, February 26, 2018 Year-end Report, January - December 2017 CADScor®System launched in key markets "In 2017, we achieved historic milestones in Acarix - most noticeably the receipt of our first [...]
INVITATION: Terveystalo Plc Full year 2017 result - Press conference and live webcast for analysts
26/02/2018
Terveystalo Plc will publish its Financial statements release 2017 on 28 February 2018 at approximately 9:00 a.m. Finnish time. The company will hold a press conference on 28 February, 2018, starting at 12:00 EET, at [...]
MediciNova to Present at the Cowen Health Care Conference in Boston
26/02/2018
LA JOLLA, Calif., Feb. 25, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
GIAPREZA™ (angiotensin II) Significantly Improved Survival of Patients with High APACHE II Scores in ATHOS-3 Study
25/02/2018
SAN DIEGO, Feb. 25, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) today announced that an abstract, entitled “ Effect of Disease Severity on Survival in Patients Receiving Angiotensin II for [...]
Agility Health Receives Conditional Approval from TSX Venture Exchange ("TSXV") for Proposed Transaction with Alliance
24/02/2018
GRAND RAPIDS, Mich., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“Agility Health” or the “Company”) announced today that it has received conditional approval from the TSXV for its previously [...]
Almost Family, Inc. to Report Fourth Quarter and Full Year 2017 Financial Results After Market Close on February 26, 2018
23/02/2018
LOUISVILLE, Ky., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Almost Family, Inc. (Nasdaq: AFAM ), a leading provider of home health nursing and personal care services, announced today that it will report financial results for its [...]

Pages